Royalty Pharma plc Class A Ordinary Shares (NASDAQ: RPRX) last traded at $57.78, up 1.49% on the session. The quote above updates while this page is open; the figures below are drawn from Royalty Pharma plc Class A Ordinary Shares’s own filings and are restated only when a new one is published.
Royalty Pharma plc Class A Ordinary Shares trades on NASDAQ under the ticker RPRX. Its market capitalisation is $32.18 billion.
Valuation measures for Royalty Pharma plc Class A Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $32.18B |
|---|---|
| Enterprise value | $41.40B |
| P/E ratio | 30.90 |
| Price / sales | 12.69 |
| Price / book | 3.29 |
| Beta |
| 0.28 |
Trailing-twelve-month figures tagged in Royalty Pharma plc Class A Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $2.54B |
|---|---|
| Net income (TTM) | $812.00M |
| EPS (TTM) | $1.87 |
| Operating margin | 59.61% |
| Return on equity | 8.30% |
| Cash | $811.99M |
Range and volume for RPRX over the past 52 weeks.
| 52-week high | $64.38 |
|---|---|
| 52-week low | $35.50 |
| Volume | 2.17M |
| Average volume | 2.92M |
| Previous close | $56.93 |
Dividend history for Royalty Pharma plc Class A Ordinary Shares over the trailing twelve months.
| Dividend yield | 1.57% |
|---|---|
| Dividend per share (TTM) | $0.910 |
| Payout ratio | 48.66% |
Invest a chosen dollar amount in Royalty Pharma plc Class A Ordinary Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RPRX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.